The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 9
- 9 renewals
- Median first-year cost
- $686,017
- $5,668,299 in all
- Institutions
- 8
- 9 contact PIs
Awards by fiscal year
0
0
9
0
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- YALE UNIVERSITY2
- BOSTON MEDICAL CENTER1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
and 3 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAA1 DD (10))9
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2016 | 2/6 COMpAAAS U01: Observation Study2U01AA020790-06 | Justice, Amy Caroline | YALE UNIVERSITY, CT | First-year cost $1,066,579 | Study section ZAA1 |
| FY2016 | Effects of experimentally-induced reductions in alcohol consumption on brain cognitive, and clinical outcomes and motivation for changing drinking in older persons with HIV infection2U01AA020797-06 | Cohen, Ronald ACook, Robert L | UNIVERSITY OF FLORIDA, FL | First-year cost $747,203 | Study section ZAA1 |
| FY2016 | 3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)2U01AA020793-06 | Crane, Heidi M.Lau, Bryan | UNIVERSITY OF WASHINGTON, WA | First-year cost $740,843 | Study section ZAA1 |
| FY2016 | URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians2U01AA020780-06 | Freiberg, Matthew SSamet, Jeffrey H.Tindle, Hilary A. | BOSTON MEDICAL CENTER, MA | First-year cost $727,673 | Study section ZAA1 |
| FY2016 | URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence2U01AA020776-06 | Hahn, Judith Alissa | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $686,017 | Study section ZAA1 |
| FY2016 | URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)2U01AA020784-06 | Saitz, Richard | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $658,000 | Study section ZAA1 |
| FY2016 | 3/6 COMpAAAS U01: Intervention Study2U01AA020795-06 | Fiellin, David | YALE UNIVERSITY, CT | First-year cost $446,622 | Study section ZAA1 |
| FY2016 | 3/3 Alcohol Research Consortium in HIV – Intervention Research Arm (ARCH-IRA)2U01AA020802-06 | Cropsey, Karen LMugavero, Michael J | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $396,390 | Study section ZAA1 |
| FY2016 | 4/6 COMpAAAS U01: Operations Research Study2U01AA020799-06 | Braithwaite, Ronald Scott | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $198,972 | Study section ZAA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.